Your browser doesn't support javascript.
loading
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer.
Mosele, F; Stefanovska, B; Lusque, A; Tran Dien, A; Garberis, I; Droin, N; Le Tourneau, C; Sablin, M-P; Lacroix, L; Enrico, D; Miran, I; Jovelet, C; Bièche, I; Soria, J-C; Bertucci, F; Bonnefoi, H; Campone, M; Dalenc, F; Bachelot, T; Jacquet, A; Jimenez, M; André, F.
Affiliation
  • Mosele F; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Stefanovska B; INSERM, Gustave Roussy Cancer Campus, UMR981, Villejuif, France.
  • Lusque A; Institut Claudius Regaud, IUCT-O, Toulouse, France.
  • Tran Dien A; Bioinformatics Platform, Gustave Roussy, Villejuif, France.
  • Garberis I; INSERM, Gustave Roussy Cancer Campus, UMR981, Villejuif, France; Paris-Saclay University, Paris, France.
  • Droin N; Genomic Core Facility UMS AMMICA Gustave Roussy, Villejuif, France.
  • Le Tourneau C; Department of Drug Development and Innovation, Institut Curie, Paris, France; INSERM U900, Saint-Cloud, France; Paris-Saclay University, Paris, France.
  • Sablin MP; Department of Medical Oncology, Institut Curie, Paris, France.
  • Lacroix L; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France; Genomic Platform and Biobank, CNRS UMS3655-INSERM US23, AMMICA, Gustave Roussy, F-94805, Villejuif, France.
  • Enrico D; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Miran I; Genomic Platform and Biobank, CNRS UMS3655-INSERM US23, AMMICA, Gustave Roussy, F-94805, Villejuif, France.
  • Jovelet C; Genomic Platform and Biobank, CNRS UMS3655-INSERM US23, AMMICA, Gustave Roussy, F-94805, Villejuif, France.
  • Bièche I; Department of Genetics, Institut Curie, Paris, France; INSERM U1016, Paris Descartes University, Paris, France.
  • Soria JC; University of Paris-Sud, Orsay, France.
  • Bertucci F; CRCM, Predictive Oncology team, Aix-Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, Marseille, France.
  • Bonnefoi H; Department of Medical Oncology, Institut Bergonie, Bordeaux, France.
  • Campone M; Department of Medical Oncology, Institut of Cancerology Ouest, Nantes, France.
  • Dalenc F; Institut Claudius Regaud, IUCT-O, Toulouse, France.
  • Bachelot T; Department of Medical Oncology, Center Leon Berard, Lyon, France.
  • Jacquet A; Precision Medicine Group, UNICANCER, Paris, France.
  • Jimenez M; Precision Medicine Group, UNICANCER, Paris, France.
  • André F; Department of Medical Oncology, Gustave Roussy, Villejuif, France; INSERM, Gustave Roussy Cancer Campus, UMR981, Villejuif, France; University of Paris-Sud, Orsay, France. Electronic address: FABRICE.ANDRE@gustaveroussy.fr.
Ann Oncol ; 31(3): 377-386, 2020 03.
Article in En | MEDLINE | ID: mdl-32067679
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Year: 2020 Type: Article